Kumagai K - Search Results

1

Pharmacologic Targeting of Histone H3K27 Acetylation/BRD4-dependent Induction of ALDH1A3 for Early-phase Drug Tolerance of Gastric Cancer.

Lee J, Mashima T, Kawata N, Yamamoto N, Morino S, Inaba S, Nakamura A, Kumagai K, Wakatsuki T, Takeuchi K, Yamaguchi K, Seimiya H. Lee J, et al. Among authors: kumagai k. Cancer Res Commun. 2024 May 20;4(5):1307-1320. doi: 10.1158/2767-9764.CRC-23-0639. Cancer Res Commun. 2024. PMID: 38669046 Free PMC article.

2

ALDH1A3-mTOR axis as a therapeutic target for anticancer drug-tolerant persister cells in gastric cancer.

Kawakami R, Mashima T, Kawata N, Kumagai K, Migita T, Sano T, Mizunuma N, Yamaguchi K, Seimiya H. Kawakami R, et al. Among authors: kumagai k. Cancer Sci. 2020 Mar;111(3):962-973. doi: 10.1111/cas.14316. Epub 2020 Feb 11. Cancer Sci. 2020. PMID: 31960523 Free PMC article.

3

In silico chemical screening identifies epidermal growth factor receptor as a therapeutic target of drug-tolerant CD44v9-positive gastric cancer cells.

Mashima T, Iwasaki R, Kawata N, Kawakami R, Kumagai K, Migita T, Sano T, Yamaguchi K, Seimiya H. Mashima T, et al. Among authors: kumagai k. Br J Cancer. 2019 Nov;121(10):846-856. doi: 10.1038/s41416-019-0600-9. Epub 2019 Oct 14. Br J Cancer. 2019. PMID: 31607750 Free PMC article.

4

Gastric Adenocarcinoma of Fundic Gland Type with Aggressive Transformation and Lymph Node Metastasis: a Case Report.

Okumura Y, Takamatsu M, Ohashi M, Yamamoto Y, Yamamoto N, Kawachi H, Ida S, Kumagai K, Nunobe S, Hiki N, Sano T. Okumura Y, et al. Among authors: kumagai k. J Gastric Cancer. 2018 Dec;18(4):409-416. doi: 10.5230/jgc.2018.18.e22. Epub 2018 Sep 4. J Gastric Cancer. 2018. PMID: 30607304 Free PMC article.

5

Timing and site-specific trends of recurrence in patients with pathological stage II or III gastric cancer after curative gastrectomy followed by adjuvant S-1 monotherapy.

Takahashi R, Ohashi M, Kano Y, Ida S, Kumagai K, Nunobe S, Chin K, Yamaguchi K, Nagino M, Sano T, Hiki N. Takahashi R, et al. Among authors: kumagai k. Gastric Cancer. 2019 Nov;22(6):1256-1262. doi: 10.1007/s10120-019-00953-9. Epub 2019 Mar 15. Gastric Cancer. 2019. PMID: 30877407

6

Different risk factors for three major recurrence patterns of pathological stage II or III gastric cancer patients who completed adjuvant S-1 monotherapy.

Kano Y, Ohashi M, Muneoka Y, Takahari D, Chin K, Yamaguchi K, Ida S, Kumagai K, Makuuchi R, Sano T, Nunobe S. Kano Y, et al. Among authors: kumagai k. Eur J Surg Oncol. 2021 Dec;47(12):3097-3104. doi: 10.1016/j.ejso.2021.04.018. Epub 2021 Apr 21. Eur J Surg Oncol. 2021. PMID: 33931261

7

Favorable long-term outcomes of one-year adjuvant S-1 monotherapy for pathological stage II or III gastric cancer treated at a high-volume center.

Kano Y, Ohashi M, Hiki N, Takahari D, Chin K, Yamaguchi K, Tsuda Y, Shoji Y, Yasufuku I, Eto K, Ida S, Kumagai K, Nunobe S, Sano T. Kano Y, et al. Among authors: kumagai k. Gastric Cancer. 2018 Nov;21(6):1024-1030. doi: 10.1007/s10120-018-0827-9. Epub 2018 Apr 26. Gastric Cancer. 2018. PMID: 29700635

8

Feasibility of further expansion of the indications for endoscopic submucosal dissection in undifferentiated-type early gastric cancer.

Horiuchi Y, Ida S, Yamamoto N, Nunobe S, Ishizuka N, Yoshimizu S, Ishiyama A, Yoshio T, Hirasawa T, Tsuchida T, Kumagai K, Ohashi M, Sano T, Fujisaki J. Horiuchi Y, et al. Among authors: kumagai k. Gastric Cancer. 2020 Mar;23(2):285-292. doi: 10.1007/s10120-019-01003-0. Epub 2019 Sep 5. Gastric Cancer. 2020. PMID: 31486980 Clinical Trial.

9

Facilitated completion of 1-year adjuvant S-1 monotherapy for pathological stage II or III gastric cancer by medical oncologists.

Kano Y, Ohashi M, Hiki N, Takahari D, Chin K, Yamaguchi K, Ida S, Kumagai K, Sano T, Nunobe S. Kano Y, et al. Among authors: kumagai k. Surg Today. 2020 Oct;50(10):1197-1205. doi: 10.1007/s00595-020-01995-8. Epub 2020 Apr 2. Surg Today. 2020. PMID: 32240378

10

Clinical outcomes of radical gastrectomy following trastuzumab-based chemotherapy for stage IV HER2-positive gastric or gastroesophageal junction cancer.

Takahashi R, Nunobe S, Osumi H, Takahari D, Yamamoto N, Ida S, Kumagai K, Ohashi M, Sano T, Hiki N. Takahashi R, et al. Among authors: kumagai k. Surg Today. 2020 Oct;50(10):1240-1248. doi: 10.1007/s00595-020-02011-9. Epub 2020 May 26. Surg Today. 2020. PMID: 32451714

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,645 results

Search Page

Filters